Flow Cytometry Market - By Products and Services (Reagents and Consumables, Instruments), By Technology (Cell-Based, Bead-Based), By Application (Immunophenotyping), By Usage (Research, Clinical), By End-use (Hospitals), & Forecast, 2023 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationFlow Cytometry Market - By Products and Services (Reagents and Consumables, Instruments), By Technology (Cell-Based, Bead-Based), By Application (Immunophenotyping), By Usage (Research, Clinical), By End-use (Hospitals), & Forecast, 2023 – 2032
Flow Cytometry Market Size
Flow Cytometry Market size valued at USD 4.9 billion in 2022 and is estimated to register over 8.4% CAGR between 2023 and 2032. Technological advancements, growing biomedical research, increasing focus on personalized medicine, rise in cancer research and immunotherapy and growing investments and collaborations among key industry players are primary growth factors that are impacting the market revenue. Increase in applications of flow cytometry in clinical diagnostics such as immunophenotyping of cells for diagnosing hematological disorders, monitoring HIV/AIDS progression, detecting minimal residual disease in leukemia, and assessing immune cell function among others.
Rising adoption flow cytometry technique in pharma companies for drug discovery and development processes, including target identification, lead compound screening, toxicity assessment, and immunogenicity testing are further fueling the flow cytometry market growth. Furthermore, rising automation level of these systems and growing demand for point-of-care diagnostics are also propelling the market expansion. Thus, the increasing demand for precise cellular analysis, expanding research areas, and rise in prevalence of infectious diseases among other variables are adding to product adoption rate.
Flow cytometry is a key technique used in biomedical research and clinical diagnostics to analyse and distinguish individual cells or particles in a heterogeneous mixture. It provides quantitative and qualitative information about various cellular properties, such as size, shape, granularity, and the presence or absence of specific biomarkers on the cell surface or within the cell.
High instrument cost, complexities associated with the technique, and limited standardization among other factors are likely to hamper the product adoption rate. The flow cytometry instruments and reagents used in the process can be expensive, making them less accessible to smaller research laboratories and resource-limited facilities. The high cost of entry and substantial maintenance expenses can limit the adoption of flow cytometry systems, thereby hindering the flow cytometry market growth. Further, availability of alternative technologies and stringent regulatory guidelines are anticipated to restrain the industry growth.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Flow Cytometry Market Size in 2022 | USD 4.9 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 8.4% |
| 2032 Value Projection | USD 11.2 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 330 |
| Tables, Charts & Figures | 742 |
| Segments covered | Products and Services, Technology, Application, Usage, End-use and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
COVID-19 Impact
Flow cytometry technique has proven to be a beneficial approach in vaccine development and monitoring and in various diagnostic applications, including immune cell profiling and identifying specific cell populations associated with COVID-19 infections. Due to its ability to analyse immune cell populations and assess immune function, flow cytometry technique became an essential tool in studying COVID-19 immunology, thus increased the demand for flow cytometry instruments and reagents. Similarly, research funding and collaboration among various end-users such as academic institutes, clinical laboratories further contributed to industry growth.
Flow Cytometry Market Trends
Technological advancements have significantly improved flow cytometry instruments, enhancing their capabilities and performance. High-parameter and multiplexing capabilities, automation and high-throughput analysis, imaging flow cytometry and improvements in optics, detectors, and signal processing are among the key parameters that are anticipated to fuel the product adoption rate. Flow cytometry instruments have evolved to accommodate higher parameter analysis, allowing simultaneous detection of more fluorescent markers.
In addition, major companies around the world are focusing on using flow cytometry while conducting research related to different fields. For instance, in October 2021, BD Life Sciences-Biosciences, in partnership with the Christian Medical College Vellore India, launched its second (CoE) center of excellence related to flow cytometry for clinical research. Such developments by leading players will enhance the flow cytometry systems adoption rate, thereby augmenting the market statistics.
Flow Cytometry Market Analysis
Based on products and services, the flow cytometry market is categorized into reagents and consumables, instruments, software, services, and accessories. The instrument segment accounted around USD 1.6 billion in 2022. The high growth rate is owing to wide application range, technological advancements, and increased research spending by multinational companies. Additionally, the compact or small-sized cytometers are predicted to witness healthy growth in coming years owing to cost-effectiveness and user-friendliness of the devices.
Flow cytometry, a cutting-edge technology, divides the market into bead-based and cell-based segments. Cell-based flow cytometry stole the show in 2022, raking in most of the revenue. And experts predict it will keep growing, hitting around 8.5 billion US dollars by 2032. Why the boom? Well, there's a growing need to catch diseases like HIV and cancer early on, and more people are turning to cell-based systems for the job. Plus, folks are finally catching on to how awesome these cell-based tests are. But that's not all – these systems are also super useful for keeping an eye on how drug treatments are working. Now, let's talk applications. Flow cytometry finds its way into different areas, including immunophenotyping, cell sorting, cell counting, cell cycle analysis, and more. Immunophenotyping, which uses antibodies to tell cells apart based on special markers on their surfaces, was the star of the show in 2022, earning over 1.8 billion US dollars. Researchers love this technique because it helps them diagnose a whole bunch of diseases, like cancer, immune system problems, and certain types of leukemia.
Based on usage, the flow cytometry market is categorized into research, clinical and industrial segments. The clinical segment is set to reach USD 4.6 billion by 2032. High segmental share is primarily attributed to rise in R&D activities related to cancer and various infectious diseases such as SARS-CoV-2 (coronavirus). Further, novel product launches incorporating technological advancements is among the key strategy adopted by industry players to augment the product adoption rate. Thus, improved product offering, shorter turnaround time, and advancements in monoclonal antibody production will further aid in diagnosis of autoimmune disease and organ transplantation conditions.
Based on end-use, the flow cytometry market is bifurcated into commercial organizations, hospitals, academic and research institutes, and clinical testing labs. The academic and research institutes segment accounted for major share in 2022 and is projected to reach around USD 3.5 billion by 2032. This technology helps in understanding the physical and chemical properties of the cells. Hence, increased R&D spending on research pertaining to various fields including marine biology, pathology, immunology and molecular biology among others is contributing to higher adoption of flow cytometry in educational and research activities.
Flow cytometry, a technology that helps us study cells, is becoming increasingly popular in hospitals and clinics, leading to a boom in demand across North America. This growth is expected to continue in the coming years, with experts predicting an impressive 7.8% jump each year until 2032. There are several reasons for this surge. As we face more people being diagnosed with diseases like cancer, the need for better ways to diagnose and treat them is urgent. Flow cytometry plays a crucial role in this, helping doctors to understand the characteristics of cancer cells and guide treatment decisions. Advances in technology have also made flow cytometry more powerful and accessible than ever before. This is attracting investment in research and development, further fueling the market's growth. North America is uniquely positioned to lead the way in this field. With its strong healthcare system, highly skilled workforce, and supportive government policies, the region is a hub for scientific research and innovation. The presence of numerous contract research organizations and large pharmaceutical companies in the area also contributes to the vibrant flow cytometry market. Overall, the North American flow cytometry market is poised for continued growth in the years to come. As the technology continues to advance and its applications expand, it will play an increasingly vital role in improving patient care and driving medical breakthroughs.
Flow Cytometry Market Share
Some of the major players operating in the flow cytometry market include
- Sony Biotechnology, Inc.
- Becton
- Dickinson and Company
- Danaher Corp
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Miltenyi Biotec, Inc.
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Luminex Corporation
These participants are involved in strategic developments such as mergers and acquisitions, novel product launch, collaboration, and research and development to improve their revenue generating capabilities.
Flow Cytometry Industry News
- In September 2022, Becton, Dickinson and Company launched BD Research Cloud. It is designed with a focus to streamline the workflow for research personnel working in different disciplines such as virology and immunology. This development will allow the company to improve their flow cytometry software offerings and enhance their business revenue.
- In June 2021, Thermo Fisher Scientific Inc. launched its Invitrogen Attune CytPix Flow Cytometer. It is an imaging-enabled flow cytometer system that combines high-speed camera with acoustic focusing flow cytometry technology. This strategic development helped the company to expand their portfolio and improve their market presence.
This flow cytometry market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Products and Services
- Reagents and Consumables
- Instruments
- Cell Analyzers
- Cell Sorters
- Software
- Services
- Accessories
By Technology
- Cell-based
- Bead-based
By Application
- Immunophenotyping
- Cell Sorting
- Cell Counting
- Cell Cycle Analysis
- Apoptosis
- Cell Proliferation Assays
- Intracellular Calcium Flux
- Others
By Usage
- Research
- Clinical
- Cancer Diagnostics
- Hematology
- Immunodeficiency
- Others
By End-use
- Commercial Organizations
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Hospitals
- Academic and Research Institutes
- Clinical Testing Labs
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Philippines
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Columbia
- Peru
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Israel
- Iran
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy